SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.36+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Torben Noerup Nielsen who wrote (29913)1/6/2000 8:47:00 PM
From: Henry Niman  Read Replies (2) of 32384
 
I would expect a LGND press release Monday night or Tuesday morning regarding new data to be presented at H&Q.

As I recall, LGND plans on a European sales force on a par with the US sales force.
businesswire.com
However, they also now have two European distribution agreements covering countries not well targeted by their developing European sales force.
businesswire.com
businesswire.com

I think that since LGND is getting up-front payments for an agreement that specifically mentions NHL, breast cancer, and psoriasis, and these indications are stated in the press release, there is a very high likelihood that LGND has seen initial Phase II data and it is encouraging.

I read tonight's press release to a precursor to some very encouraging clinical data and would not be surprised to see LGND set a 52 week high prior to their H&Q presentation on Tuesday.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext